TCL Archive Genentech Says Phase III Trial Shows Avastin Improved PFS For Ovarian Cancer March 26, 2010
TCL Archive DCT Board Approves Proposals For Increased Efforts With Biological Response Modifiers, Oks Contracts November 9, 1979